Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), Туре (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Global Forecast 2024-2030
The Clinical Trial Supplies Market size was estimated at USD 3.35 billion in 2023 and expected to reach USD 3.64 billion in 2024, at a CAGR 8.43% to reach USD 5.92 billion by 2030.
Clinical trial supplies are a fundamental yet complex component of clinical research, ultimately helping pave the way toward successful therapeutic breakthroughs and monumental enhancements in patient care pathways. These supplies cater to various research phases, from pre-clinical examinations to post-marketing surveillance studies, thus facilitating the seamless management and execution of clinical investigations. The increasing prevalence of infectious and chronic diseases worldwide and the subsequent rise in clinical trials with research and development expenditure of the pharmaceutical and biopharmaceutical industry stimulates market growth. The high cost associated with clinical trial supplies, stringent regulations for supplies, and cross-border logistics challenges restrict market growth. Growing emphasis on drug development and shifting towards patient-centric clinical trials offer the potential for better clinical trial patient recruitment, study enrollment, and participant retention. In addition, ongoing advancements in a diverse range of clinical trial supplies are expected to open new research avenues for pharmaceutical and biopharmaceutical companies.
Regional Insights
In the Americas, primarily the United States and Canada, there is a significant dependence on clinical trial supplies due to a high diagnosis rate of chronic diseases and robust healthcare infrastructure. Over the past year, the major patents registered revolved around optimizing supply chain models and employing advanced analytics to align trial supply with demand. The European Union (EU), the Middle East, and Africa exhibit a diverse range of needs due to discrepancies in healthcare access and spending. Europe witnesses steady demand for clinical trial supplies, fueled by heavy investments in research and development initiatives and a surge in the geriatric population. In contrast, Middle Eastern and African countries encompass emerging markets with rising research activities yet laid back due to limited funding and infrastructural impediments. Asia-Pacific, including China, Japan, and India, reports a high disease prevalence, bridged by substantial investments in improving healthcare infrastructure. The booming pharmaceutical industry drives the clinical trial supplies market in these regions, and the demand is dictated more by cost-efficacy rather than speed, mirroring their unique healthcare economic dynamics.
Market Insights
- Market Dynamics
The market dynamics represent an ever-changing landscape of the Clinical Trial Supplies Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.- Market Drivers
- Increasing prevalence of infectious and chronic diseases worldwide
- Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
- Market Restraints
- High cost of clinical trial supplies
- Market Opportunities
- Emphasis on drug development and shift towards patient-centric clinical trials
- Ongoing advancements in a diverse range of clinical trial supplies
- Market Challenges
- Stringent regulations for clinical trial supplies
- Market Segmentation Analysis
- Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
- Туре: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
- Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
- Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
- End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Clinical Trial Supplies Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Clinical Trial Supplies Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments- Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal
Permira, a UK private equity firm, agreed to acquire Ergomed for USD 888.1 million. Ergomed is a clinical trial development and management services provider, catering to clients across more than 100 countries. This strategic acquisition can expand Permira's already impressive portfolio of medical companies, including Neurapharm and Cambrex.
Thermo Fisher Scientific Launches New Smart Refrigerator Series
Thermo Fisher Scientific introduced the Thermo Scientific TM TSG series refrigerators, specifically engineered to cater to the stringent demands of diverse industries. These cutting-edge refrigerators leverage advanced technology to ensure accurate temperature control, effectively preserving the integrity of vaccines and pharmaceuticals. By minimizing temperature fluctuations, these refrigerators effectively mitigate the risks associated with such variations, safeguarding medical products' potency and efficacy.
Loftware and Tenthpin Collaborate on Clinical Supply Labeling
Loftware and Tenthpin collaborated to launch a software called Loftware Prisym 360, which is specifically designed for clinical supply labeling. The main objective of this partnership is to address the growing challenges faced by clinical trial supply teams within the pharmaceutical industry. This agreement enables both Loftware and Tenthpin to actively promote, educate, and implement a comprehensive content and labeling solution for their clinical customers.
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Clinical Trial Supplies Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Clinical Trial Supplies Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Almac Group Limited, B. Braun SE, Baxter International, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Cardinal Health, Inc., Charles River Laboratories, Inc., COREX LOGISTICS LIMITED, Emsere B.V by Medicapital Holdco B.V., Eppendorf SE, Evident Corporation by Olympus Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Group, Hipro Biotechnology Co., Ltd., Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Immudex ApS, Incyte Corporation, IQVIA Inc., Johnson & Johnson Services, Inc., KLIFO A/S, Labnet International, Leica Microsystems GmbH by Danaher Corporation, llumina, Inc., Lonza Group Ltd., Medline Industries, LP, Merck KGaA, Myonex, LLC, Novo Nordisk A/S, Nuvisan GmbH, Parexel International Corporation, Perceptive Informatics LLC and its affiliates, d/b/a Calyx, PerkinElmer Inc. by Revvity, Inc., Pfizer Inc., Promega Corporation, Recipharm AB, Rubicon Research Pvt. Ltd., Sekisui Diagnostics Group, Sharp Services, LLC, Siemens Healthcare GmbH, Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific Inc., and Woodley Equipment Company Ltd..
Market Segmentation & Coverage
This research report categorizes the Clinical Trial Supplies Market to forecast the revenues and analyze trends in each of the following sub-markets:- Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- Туре
- Biologic Drugs
- Medical Devices
- Small-Molecules
- Product
- Auxiliary Medicinal Products
- Interactive Response Technology (IRT) solutions
- Lab Supplies
- Centrifuges
- Microscopes
- Pipettes
- Reagents
- Medical Devices & Diagnostics
- Pharmacy Supplies
- Biohazard Bags
- Compounding Aseptic Isolators
- Sterilization Equipment
- Research Materials
- Safety Equipment
- Therapeutic Area
- Cardiology
- Genetic Diseases
- Immunology
- Infectious Diseases
- Metabolic Disorders
- Neurology
- Oncology
- End User
- Contract Research Organisations
- Pharmaceutical & Biotechnology Companies
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
- Americas
- Market Drivers
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
- 5.1.1.2. Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
- 5.1.2. Restraints
- 5.1.2.1. High cost of clinical trial supplies
- 5.1.3. Opportunities
- 5.1.3.1. Emphasis on drug development and shift towards patient-centric clinical trials
- 5.1.3.2. Ongoing advancements in a diverse range of clinical trial supplies
- 5.1.4. Challenges
- 5.1.4.1. Stringent regulations for clinical trial supplies
- 5.2. Market Segmentation Analysis
- 5.2.1. Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
- 5.2.2. Туре: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
- 5.2.3. Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
- 5.2.4. Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
- 5.2.5. End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
- 5.3. Market Trend Analysis
- 5.3.1. Well-established pharmaceutical companies emphasis on increasing the number of clinical trials, propelling the need for clinical trial supplies in the Americas
- 5.3.2. Expanding government initiatives to strengthen the clinical trial capabilities coupled with supportive regulations and standards in the APAC region
- 5.3.3. Increasing number of clinical trials and strong and advanced pharmaceutical sector in the EMEA
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework Analysis
- 6. Clinical Trial Supplies Market, by Phase
- 6.1. Introduction
- 6.2. Phase I
- 6.3. Phase II
- 6.4. Phase III
- 6.5. Phase IV
- 7. Clinical Trial Supplies Market, by Туре
- 7.1. Introduction
- 7.2. Biologic Drugs
- 7.3. Medical Devices
- 7.4. Small-Molecules
- 8. Clinical Trial Supplies Market, by Product
- 8.1. Introduction
- 8.2. Auxiliary Medicinal Products
- 8.3. Interactive Response Technology (IRT) solutions
- 8.4. Lab Supplies
- 8.5. Medical Devices & Diagnostics
- 8.6. Pharmacy Supplies
- 8.7. Research Materials
- 8.8. Safety Equipment
- 9. Clinical Trial Supplies Market, by Therapeutic Area
- 9.1. Introduction
- 9.2. Cardiology
- 9.3. Genetic Diseases
- 9.4. Immunology
- 9.5. Infectious Diseases
- 9.6. Metabolic Disorders
- 9.7. Neurology
- 9.8. Oncology
- 10. Clinical Trial Supplies Market, by End User
- 10.1. Introduction
- 10.2. Contract Research Organisations
- 10.3. Pharmaceutical & Biotechnology Companies
- 11. Americas Clinical Trial Supplies Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific Clinical Trial Supplies Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
- 13. Europe, Middle East & Africa Clinical Trial Supplies Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.10. Nigeria
- 13.11. Norway
- 13.12. Poland
- 13.13. Qatar
- 13.14. Russia
- 13.15. Saudi Arabia
- 13.16. South Africa
- 13.17. Spain
- 13.18. Sweden
- 13.19. Switzerland
- 13.20. Turkey
- 13.21. United Arab Emirates
- 13.22. United Kingdom
- 14. Competitive Landscape
- 14.1. Market Share Analysis, 2023
- 14.2. FPNV Positioning Matrix, 2023
- 14.3. Competitive Scenario Analysis
- 14.3.1. Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal
- 14.3.2. Thermo Fisher Scientific Launches New Smart Refrigerator Series
- 14.3.3. Loftware and Tenthpin Collaborate on Clinical Supply Labeling
- 14.3.4. Sitero Acquires Clario’s eClinical Technology Suite to Enhance Clinical Trial Delivery
- 14.3.5. Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
- 14.3.6. BD Launches New Robotic System to Automate Clinical Flow Cytometry
- 14.3.7. Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
- 14.3.8. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma
- 14.3.9. Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
- 14.3.10. Siemens Healthineers Launch Laboratory Equipment R&D Centre in Swords
- 14.3.11. Experic Closes USD 14 Million Series B Financing
- 14.3.12. Medline Invests Additional USD 500M in Medical Supply Inventory to Boost Product Availability
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.2. Key Product Portfolio
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook